These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

99 related articles for article (PubMed ID: 20558939)

  • 1. Successful chemotherapy for small-cell lung cancer in an elderly patient undergoing continuous ambulatory peritoneal dialysis.
    Tanizawa K; Fukunaga K; Okumura N; Sugimura M; Tanaka E; Hajiro T; Sakuramoto M; Minakuchi M; Hashimoto S; Yasuda T; Kaji Y; Ikezoe K; Sato E; Nakajima T; Taguchi Y
    Intern Med; 2010; 49(12):1179-83. PubMed ID: 20558939
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [A Case of Small Cell Lung Cancer Treated with Concurrent Chemoradiotherapy with Carboplatin plus Etoposide in a Hemodialysis Patient].
    Terashima T; Iwami E; Chubachi S; Ikemura S; Nakajima T; Matsuzaki T; Aoyagi H
    Gan To Kagaku Ryoho; 2016 Jan; 43(1):99-101. PubMed ID: 26809534
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pharmacokinetic analysis of carboplatin and etoposide in a small cell lung cancer patient undergoing hemodialysis.
    Takezawa K; Okamoto I; Fukuoka M; Nakagawa K
    J Thorac Oncol; 2008 Sep; 3(9):1073-5. PubMed ID: 18758316
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Dosing of carboplatin in a patient with amputated legs: A case report.
    van Gorp F; van Rens MT; Kuck EM; Rozemeijer R; Huitema AD; Brouwers EE
    J Oncol Pharm Pract; 2014 Dec; 20(6):473-5. PubMed ID: 24356803
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Phase I and pharmacologic study of sequential topotecan-carboplatin-etoposide in patients with extensive stage small cell lung cancer.
    Miller AA; Al Omari A; Murry DJ; Case D
    Lung Cancer; 2006 Dec; 54(3):379-85. PubMed ID: 17049403
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Use of high-dose etoposide/ifosfamide/carboplatin/epirubicin and peripheral blood progenitor cell transplantation in limited-disease small cell lung cancer.
    Brugger W; Frommhold H; Pressler K; Mertelsmann R; Kanz L
    Semin Oncol; 1995 Feb; 22(1 Suppl 2):3-8. PubMed ID: 7531368
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Phase II study of area under the plasma-concentration-versus-time curve-based carboplatin plus standard-dose intravenous etoposide in elderly patients with small-cell lung cancer.
    Okamoto H; Watanabe K; Nishiwaki Y; Mori K; Kurita Y; Hayashi I; Masutani M; Nakata K; Tsuchiya S; Isobe H; Saijo N
    J Clin Oncol; 1999 Nov; 17(11):3540-5. PubMed ID: 10550152
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A phase II study of carboplatin, etoposide, and exisulind in patients with extensive small cell lung cancer: CALGB 30104.
    Govindan R; Wang X; Baggstrom MQ; Burdette-Radoux S; Hodgson L; Vokes EE; Green MR;
    J Thorac Oncol; 2009 Feb; 4(2):220-6. PubMed ID: 19179900
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Triplet combination of carboplatin, irinotecan, and etoposide in the first-line treatment of extensive small-cell lung cancer: a single-institution phase II study.
    Charpidou A; Tsagouli S; Tsimpoukis S; Vassias A; Makrilia N; Stratakos G; Gkiozos I; Syrigos K
    Anticancer Drugs; 2010 Jul; 21(6):651-5. PubMed ID: 20386306
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Paclitaxel, carboplatin, and extended-schedule etoposide in the treatment of small-cell lung cancer: comparison of sequential phase II trials using different dose-intensities.
    Hainsworth JD; Gray JR; Stroup SL; Kalman LA; Patten JE; Hopkins LG; Thomas M; Greco FA
    J Clin Oncol; 1997 Dec; 15(12):3464-70. PubMed ID: 9396399
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A randomized phase III study of single-agent amrubicin vs. carboplatin/etoposide in elderly patients with extensive-disease small-cell lung cancer.
    Sekine I; Okamoto H; Horai T; Nakagawa K; Ohmatsu H; Yokoyama A; Katakami N; Shibuya M; Saijo N; Fukuoka M
    Clin Lung Cancer; 2014 Mar; 15(2):96-102. PubMed ID: 24361248
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Double-cycle, high-dose ifosfamide, carboplatin, and etoposide followed by peripheral blood stem-cell transplantation for small cell lung cancer.
    Iwasaki Y; Nagata K; Nakanishi M; Natuhara A; Kubota Y; Ueda M; Arimoto T; Hara H
    Chest; 2005 Oct; 128(4):2268-73. PubMed ID: 16236883
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Paclitaxel, carboplatin, and oral etoposide in the treatment of small cell lung cancer.
    Greco FA; Hainsworth JD
    Semin Oncol; 1996 Dec; 23(6 Suppl 16):7-10. PubMed ID: 9007113
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pharmacokinetically guided dosing of carboplatin and etoposide during peritoneal dialysis and haemodialysis.
    English MW; Lowis SP; Peng B; Boddy A; Newell DR; Price L; Pearson AD
    Br J Cancer; 1996 Mar; 73(6):776-80. PubMed ID: 8611379
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Combination chemotherapy with carboplatin and etoposide against lung adenocarcinoma in a patient undergoing hemodialysis: a case report].
    Yanagawa H; Takishita Y; Bando H; Shinohara T; Tanaka H; Sumitani H
    Gan To Kagaku Ryoho; 1993 Dec; 20(15):2409-11. PubMed ID: 8259862
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Tolerability and efficacy of IMpower133 regimen modified for dialysis patients with extensive-stage small cell lung cancer: Two case reports.
    Watari N; Yamaguchi K; Masuda T; Ito N; Sakamoto S; Horimasu Y; Miyamoto S; Nakashima T; Iwamoto H; Fujitaka K; Hamada H; Hattori N
    Thorac Cancer; 2021 Nov; 12(21):2956-2960. PubMed ID: 34587368
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Treatment of germ cell cancer with two cycles of high-dose ifosfamide, carboplatin, and etoposide with autologous stem-cell support.
    Margolin K; Doroshow JH; Ahn C; Hamasaki V; Leong L; Morgan R; Raschko J; Shibata S; Somlo G; Tetef M
    J Clin Oncol; 1996 Oct; 14(10):2631-7. PubMed ID: 8874321
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Durvalumab plus carboplatin-etoposide treatment in a patient with small-cell lung cancer on hemodialysis: a case report and literature review.
    Ushijima F; Hase T; Yamashita Y; Kim H; Shimokata T; Kondo C; Sato T; Baba T; Watanabe S; Futamura K; Ando Y; Mizuno M; Ishii M
    Int Cancer Conf J; 2024 Apr; 13(2):88-92. PubMed ID: 38524642
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Phase II trial of paclitaxel-topotecan-etoposide followed by consolidation chemoradiotherapy for limited-stage small cell lung cancer: CALGB 30002.
    Miller AA; Wang XF; Bogart JA; Hodgson LD; Rocha Lima CM; Radford JE; Vokes EE; Green MR;
    J Thorac Oncol; 2007 Jul; 2(7):645-51. PubMed ID: 17607121
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A phase I study of dose-dense topotecan given upfront to standard therapy in patients with small cell lung cancer.
    Garst J; Herndon JE; Shafman T; Campagna L; Blackwell S; Padilla K; Bjurstrom T; Andrews C; Maravich-May D; Anderson E; Crawford J
    Clin Drug Investig; 2006; 26(5):257-66. PubMed ID: 17163259
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.